Compare NeoGenomics Inc. Common Stock (NEO) vs Sotera Health Company Common Stock (SHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Sotera Health Company Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.06B). The key difference: Sotera Health Company Common Stock is far larger — about 2.3× NeoGenomics Inc. Common Stock's market cap, and Sotera Health Company Common Stock is more actively traded (2,279,715 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| NEO | SHC | |
|---|---|---|
Market Cap | $2.17B | $5.06B |
Volume | 1,615,943 | 2,279,715 |
Sector | Health | Health |
52-Week High | $19.91 | $19.57 |
52-Week Low | $7.19 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $6.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Sotera Health Company Common Stock
Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →
